chr17-38352600-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014598.4(SOCS7):c.548G>A(p.Gly183Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Consequence
SOCS7
NM_014598.4 missense
NM_014598.4 missense
Scores
3
12
Clinical Significance
Conservation
PhyloP100: 1.05
Genes affected
SOCS7 (HGNC:29846): (suppressor of cytokine signaling 7) Predicted to enable 1-phosphatidylinositol-3-kinase regulator activity. Predicted to be involved in phosphatidylinositol phosphate biosynthetic process. Predicted to act upstream of or within several processes, including brain development; fat cell differentiation; and insulin receptor signaling pathway. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14906973).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOCS7 | NM_014598.4 | c.548G>A | p.Gly183Asp | missense_variant | 1/10 | ENST00000612932.6 | NP_055413.2 | |
SOCS7 | XM_017024551.2 | c.548G>A | p.Gly183Asp | missense_variant | 1/9 | XP_016880040.1 | ||
SOCS7 | XM_017024552.2 | c.548G>A | p.Gly183Asp | missense_variant | 1/8 | XP_016880041.1 | ||
SOCS7 | XR_007065295.1 | n.757G>A | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOCS7 | ENST00000612932.6 | c.548G>A | p.Gly183Asp | missense_variant | 1/10 | 1 | NM_014598.4 | ENSP00000482229.2 | ||
SOCS7 | ENST00000665913.1 | c.356G>A | p.Gly119Asp | missense_variant | 1/10 | ENSP00000499750.1 | ||||
SOCS7 | ENST00000613678.5 | c.371G>A | p.Gly124Asp | missense_variant | 1/9 | 5 | ENSP00000484381.2 | |||
SOCS7 | ENST00000617360.1 | n.50G>A | non_coding_transcript_exon_variant | 1/9 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.356G>A (p.G119D) alteration is located in exon 1 (coding exon 1) of the SOCS7 gene. This alteration results from a G to A substitution at nucleotide position 356, causing the glycine (G) at amino acid position 119 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Pathogenic
D
Sift4G
Benign
T;T
Polyphen
0.19
.;B
Vest4
MutPred
Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at